Rheuma Tv
A recent phase II clinical trial published in Rheumatic and Musculoskeletal Diseases has revealed promising outcomes for jaktinib hydrochloride, a Janus kinase inhibitor (JAK) , …
The phase 3 BLISS-BELIEVE trial provided valuable insights into the efficacy and safety of sequential therapy with subcutaneous belimumab (BEL) and a single cycle of …
A recent study published in The Journal of Nutritional Biochemistry shed light on the role of selenium (Se) and its associated proteins, Selenoprotein P (SELENOP) and …
The FOREMOST trial results published in the Annals of the Rheumatic Diseases demonstrated the potential of apremilast in significantly improving outcomes for patients in the …
A recent study published in Human Molecular Genetics has spotlighted E74-like factor 1 (ELF1) as a potential biomarker for disease activity and renal involvement in …
In a significant development for rheumatoid arthritis (RA) management, interim results from the long-term FINCH 4 extension study published in Rheumatic and Musculoskeletal Diseases Open …
A single-blind, randomized controlled trial conducted in A Coruña, Spain, has provided evidence that aquatic therapy (AT) outperforms land-based therapy (LBT) in managing pain and …
Primary Sjögren’s syndrome (pSS), characterized by lymphocyte infiltration into exocrine glands, poses significant challenges due to its heterogeneous presentation and overlap with other autoimmune diseases. …
Riociguat is primarily indicated for the management of pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH). A recent phase 2b RISE-SSc trial, published …